This person is not registered. Is this you?


Profile Details
Ralph Weissleder
Affiliations:

Massachusetts General Hospital Radiology

 
, USA
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
 
Age:
Bio:
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Biology, Biotechnology, Cancer Biology, Cell Biology, Epidemiology, Genomics, Hematology, Hepatology, Histology, Immunology, Leukemia, Microscopy, Molecular Biology, Oncology, Peptides, Pharmacology, Proteomics, Stem Cells, Translational Research
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 4747 / 2941 (What's this?)
Accomplish Score: 38
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 75
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 2 (26 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 2 (12 / 0)
  • Programmed death ligand 1 (PD-L1) is expressed on a number of immune and cancer cells, where it can downregulate antitumor immune responses. ()
  • Anticancer nanotherapeutics have shown mixed results in clinical trials, raising the questions of whether imaging should be used to i) identify patients with a higher likelihood of nanoparticle accumulation, ii) assess nanotherapeutic efficacy before traditional measures show response, and iii) guide adjuvant treatments to enhance therapeutic nanoparticle (TNP) delivery. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.